查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1614270

体外循环系统市场：按产品类型、应用和最终用户划分 - 全球预测 2025-2030

Extracorporeal Circulation System Market by Product (Blood Filters, Cannulae, Heart-Lung Machines), Type (Bench Top, Portable), Application, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年体外循环系统市值为13.5亿美元，预计2024年将达到14.6亿美元，复合年增长率为8.11%，到2030年将达到23.4亿美元。

体外循环系统市场主要包括用于在心血管手术期间管理患者体外血液循环的医疗设备和技术。通常，这些系统对于需要血液在没有心臟帮助的情况下循环的手术至关重要，例如冠状动脉绕道手术手术 (CABG)、心臟移植和其他心血管手术。该系统用于医院、心臟诊所和医学研究机构。其最终用途范围扩展到成人和儿童心血管手术，这表明它可以根据患者属性用于多种目的。关键的成长要素包括心血管疾病的增加、医疗技术的进步以及微创技术的采用增加。世界人口老化将进一步推动需求，因为老年人更容易患上需要这些系统的心臟病。由于医疗保健投资的增加和未满足的医疗需求，新兴市场提供了潜在的商机。製造商可以透过扩大其地理分布并提高其产品的承受能力来利用这一点。然而，高成本和严格的监管审批为市场拓展带来了挑战。留住熟练的专业人员也是一个挑战，特别是在发展中地区。技术创新的目标是提高系统效率、减小设备尺寸以方便操作，以及整合数位技术以实现更好的监测和治疗结果。生物相容性材料和人工智慧的应用研究有可能推动进步并提供更好的患者照护和系统效率。该市场的特点是现有参与者和新进入者之间竞争激烈，需要持续创新和策略联盟来实现业务成长。分析患者需求和监管环境有助于协调市场开拓和产品开发。总体而言，体外循环系统市场是动态的，儘管存在固有的挑战，但仍具有显着的进步和成长机会。

主要市场统计
基准年[2023] 13.5亿美元
预测年份 [2024] 14.6亿美元
预测年份 [2030] 23.4亿美元
复合年增长率（%） 8.11%

市场动态：快速发展的体外循环系统市场的关键市场洞察

供需的动态交互作用正在改变体外循环系统市场。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助企业了解消费行为及其对製造业的影响。

  • 市场驱动因素
    • 不断改进帮浦设计、供氧设备和监测系统等医疗技术
    • 心血管手术数量增加，包括心臟移植和绕道手术
  • 市场限制因素
    • 与体外循环系统相关的高成本和风险
  • 市场机会
    • 新兴国家医疗保健投资和基础建设增加
    • 材料、技术以及与其他医疗设备相容性的研究和创新
  • 市场挑战
    • 法规遵循、技术培训和招聘

波特五力：驾驭体外循环系统市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解体外循环系统市场的外部影响

外部宏观环境因素在塑造体外循环系统市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助企业预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解体外循环系统市场的竞争状况

对体外循环系统市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵体外循环系统市场供应商的绩效评估

FPNV定位矩阵是评估体外循环系统市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，以确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议，描绘体外循环系统市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对体外循环系统市场的策略分析至关重要。透过考虑关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 不断改进帮浦设计、充氧设备、监测系统等医疗技术
      • 心血管手术数量增加，包括心臟移植和绕道手术
    • 抑制因素
      • 与体外循环系统相关的高成本和风险
    • 机会
      • 新兴国家增加医疗保健投资和改善基础设施
      • 材料、技术以及与其他医疗设备相容性的研究和创新
    • 任务
      • 监管合规和技术培训和招聘
  • 市场区隔分析
    • 产品：血液过滤器技术不断进步，提高效率和病人安全
    • 应用：全球心血管手术的发生率不断增加，增加了体外循环系统的需求。
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章体外循环系统市场：副产品

  • 血液过滤器
  • 插管
  • 心肺机
  • 供氧装置
  • 水库

第七章体外循环系统市场：依类型

  • 桌上型
  • 可携式的

第八章体外循环系统市场：依应用分类

  • 心血管手术
  • 肺移植

第九章体外循环系统市场：依最终用户分类

  • 医院
  • 调查机构
  • 专科诊所

第十章北美及南美体外循环系统市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太体外循环系统市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章欧洲、中东和非洲体外循环系统市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • FDA核准LivaNova 的 LifeSPARC 系统用于 ECMO
  • 战略分析和建议

公司名单

  • Abbott Laboratories
  • BIOTRONIK
  • Boston Scientific
  • CardioFocus
  • Edwards Lifesciences
  • EUROSETS Srl
  • LivaNova PLC
  • Maquet Holding BV & Co. KG by Getinge Group
  • Medtronic PLC
  • MicroPort Scientific Corporation
  • Nipro Corporation
  • OriGen Biomedical, Inc.
  • Philips Healthcare
  • Siemens Healthineers
  • Terumo Corporation
  • XENIOS AG by Fresenius Medical Care AG & Co. KGaA
Product Code: MRR-CD5A9334D17A

The Extracorporeal Circulation System Market was valued at USD 1.35 billion in 2023, expected to reach USD 1.46 billion in 2024, and is projected to grow at a CAGR of 8.11%, to USD 2.34 billion by 2030.

The extracorporeal circulation system market encompasses medical devices and technologies used primarily during cardiac surgeries to manage the circulation of blood outside the patient's body. Typically, these systems are vital in procedures such as coronary artery bypass grafting (CABG), heart transplants, and other cardiac surgeries, necessitating blood circulation without the assistance of the heart. The system finds applications across hospitals, specialized heart clinics, and medical research facilities. Its end-use scope spans adult and pediatric cardiac surgeries, indicating versatile use based on patient demographics. Key growth factors include increasing incidences of cardiovascular diseases, advancements in medical technology, and the rising adoption of minimally invasive techniques. The aging global population further propels demand, as older adults are more susceptible to heart conditions requiring these systems. Potential opportunities lie in emerging markets due to rising healthcare investments and unmet medical needs. Manufacturers can capitalize on this by expanding their geographical presence and enhancing product affordability. However, limitations due to high costs and stringent regulatory approvals challenge market expansion. The requirement for skilled professionals poses another challenge, especially in developing regions. Innovation can target enhancing system efficiency, reducing device size for easier handling, and integrating digital technologies for better monitoring and outcomes. Research into biocompatible materials and artificial intelligence applications can drive advancement, potentially offering better patient care and system efficiency. The market, characterized by robust competition among established players and new entrants, requires sustained innovation and strategic alliances for business growth. Analyzing patient needs and regulatory landscapes can offer insights, aiding companies in aligning product development with market demands. Overall, the extracorporeal circulation system market is dynamic, with opportunities for significant advancements and growth despite its inherent challenges.

KEY MARKET STATISTICS
Base Year [2023] USD 1.35 billion
Estimated Year [2024] USD 1.46 billion
Forecast Year [2030] USD 2.34 billion
CAGR (%) 8.11%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Extracorporeal Circulation System Market

The Extracorporeal Circulation System Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Continuous improvement in medical technologies, including pump designs, oxygenators, and monitoring systems
    • Rise in the number of cardiovascular surgeries, including heart transplants and bypass surgeries
  • Market Restraints
    • high cost and risk associated with extracorporeal circulation system
  • Market Opportunities
    • Increasing healthcare investment and infrastructure improvements in emerging economies
    • Research and innovations in materials, techniques, and compatibility with other medical devices
  • Market Challenges
    • Regulatory compliance and technical training and adoption

Porter's Five Forces: A Strategic Tool for Navigating the Extracorporeal Circulation System Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Extracorporeal Circulation System Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Extracorporeal Circulation System Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Extracorporeal Circulation System Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Extracorporeal Circulation System Market

A detailed market share analysis in the Extracorporeal Circulation System Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Extracorporeal Circulation System Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Extracorporeal Circulation System Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Extracorporeal Circulation System Market

A strategic analysis of the Extracorporeal Circulation System Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Extracorporeal Circulation System Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, BIOTRONIK, Boston Scientific, CardioFocus, Edwards Lifesciences, EUROSETS S.r.l., LivaNova PLC, Maquet Holding B.V. & Co. KG by Getinge Group, Medtronic PLC, MicroPort Scientific Corporation, Nipro Corporation, OriGen Biomedical, Inc., Philips Healthcare, Siemens Healthineers, Terumo Corporation, and XENIOS AG by Fresenius Medical Care AG & Co. KGaA.

Market Segmentation & Coverage

This research report categorizes the Extracorporeal Circulation System Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Blood Filters, Cannulae, Heart-Lung Machines, Oxygenators, and Reservoirs.
  • Based on Type, market is studied across Bench Top and Portable.
  • Based on Application, market is studied across Cardiac Surgeries and Lung Transplantation.
  • Based on End-User, market is studied across Hospitals, Research Institutions, and Specialty Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Continuous improvement in medical technologies, including pump designs, oxygenators, and monitoring systems
      • 5.1.1.2. Rise in the number of cardiovascular surgeries, including heart transplants and bypass surgeries
    • 5.1.2. Restraints
      • 5.1.2.1. high cost and risk associated with extracorporeal circulation system
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing healthcare investment and infrastructure improvements in emerging economies
      • 5.1.3.2. Research and innovations in materials, techniques, and compatibility with other medical devices
    • 5.1.4. Challenges
      • 5.1.4.1. Regulatory compliance and technical training and adoption
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Ongoing technological advancements in blood filters to enhance efficiency and patient safety
    • 5.2.2. Application: Growing incidences of cardiac surgeries globally boost the demand for extracorporeal circulation systems
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Extracorporeal Circulation System Market, by Product

  • 6.1. Introduction
  • 6.2. Blood Filters
  • 6.3. Cannulae
  • 6.4. Heart-Lung Machines
  • 6.5. Oxygenators
  • 6.6. Reservoirs

7. Extracorporeal Circulation System Market, by Type

  • 7.1. Introduction
  • 7.2. Bench Top
  • 7.3. Portable

8. Extracorporeal Circulation System Market, by Application

  • 8.1. Introduction
  • 8.2. Cardiac Surgeries
  • 8.3. Lung Transplantation

9. Extracorporeal Circulation System Market, by End-User

  • 9.1. Introduction
  • 9.2. Hospitals
  • 9.3. Research Institutions
  • 9.4. Specialty Clinics

10. Americas Extracorporeal Circulation System Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Extracorporeal Circulation System Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Extracorporeal Circulation System Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. FDA Approves LivaNova's LifeSPARC System for ECMO Use
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. BIOTRONIK
  • 3. Boston Scientific
  • 4. CardioFocus
  • 5. Edwards Lifesciences
  • 6. EUROSETS S.r.l.
  • 7. LivaNova PLC
  • 8. Maquet Holding B.V. & Co. KG by Getinge Group
  • 9. Medtronic PLC
  • 10. MicroPort Scientific Corporation
  • 11. Nipro Corporation
  • 12. OriGen Biomedical, Inc.
  • 13. Philips Healthcare
  • 14. Siemens Healthineers
  • 15. Terumo Corporation
  • 16. XENIOS AG by Fresenius Medical Care AG & Co. KGaA

LIST OF FIGURES

  • FIGURE 1. EXTRACORPOREAL CIRCULATION SYSTEM MARKET RESEARCH PROCESS
  • FIGURE 2. EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. EXTRACORPOREAL CIRCULATION SYSTEM MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. EXTRACORPOREAL CIRCULATION SYSTEM MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. EXTRACORPOREAL CIRCULATION SYSTEM MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. EXTRACORPOREAL CIRCULATION SYSTEM MARKET DYNAMICS
  • TABLE 7. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY BLOOD FILTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CANNULAE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY HEART-LUNG MACHINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY OXYGENATORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY RESERVOIRS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY BENCH TOP, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PORTABLE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY CARDIAC SURGERIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY LUNG TRANSPLANTATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY RESEARCH INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. MEXICO EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 54. AUSTRALIA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. AUSTRALIA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 58. CHINA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. CHINA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 62. INDIA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. INDIA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 66. INDONESIA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. INDONESIA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 70. JAPAN EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. JAPAN EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 74. MALAYSIA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. MALAYSIA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 78. PHILIPPINES EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. PHILIPPINES EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. PHILIPPINES EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 82. SINGAPORE EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 83. SINGAPORE EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. SINGAPORE EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. SINGAPORE EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH KOREA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH KOREA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH KOREA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 90. TAIWAN EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 91. TAIWAN EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. TAIWAN EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. TAIWAN EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 94. THAILAND EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 95. THAILAND EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. THAILAND EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. THAILAND EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 98. VIETNAM EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 99. VIETNAM EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. VIETNAM EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. VIETNAM EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 107. DENMARK EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 108. DENMARK EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. DENMARK EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 110. DENMARK EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 111. EGYPT EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 112. EGYPT EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. EGYPT EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. EGYPT EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 115. FINLAND EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 116. FINLAND EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. FINLAND EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. FINLAND EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 119. FRANCE EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 120. FRANCE EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. FRANCE EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 122. FRANCE EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 123. GERMANY EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 124. GERMANY EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. GERMANY EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. GERMANY EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 127. ISRAEL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 128. ISRAEL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. ISRAEL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 130. ISRAEL EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 131. ITALY EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 132. ITALY EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. ITALY EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 134. ITALY EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 135. NETHERLANDS EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 136. NETHERLANDS EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. NETHERLANDS EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 139. NIGERIA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 140. NIGERIA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. NIGERIA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. NIGERIA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 143. NORWAY EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 144. NORWAY EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. NORWAY EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 146. NORWAY EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 147. POLAND EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 148. POLAND EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 149. POLAND EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 150. POLAND EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 151. QATAR EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 152. QATAR EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 153. QATAR EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 154. QATAR EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 155. RUSSIA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 156. RUSSIA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 157. RUSSIA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 158. RUSSIA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 159. SAUDI ARABIA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 160. SAUDI ARABIA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 162. SAUDI ARABIA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH AFRICA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH AFRICA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH AFRICA EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 167. SPAIN EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 168. SPAIN EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 169. SPAIN EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 170. SPAIN EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 171. SWEDEN EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 172. SWEDEN EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 173. SWEDEN EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 174. SWEDEN EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 175. SWITZERLAND EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 176. SWITZERLAND EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 178. SWITZERLAND EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 179. TURKEY EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 180. TURKEY EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 181. TURKEY EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 182. TURKEY EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED ARAB EMIRATES EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED KINGDOM EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED KINGDOM EXTRACORPOREAL CIRCULATION SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 191. EXTRACORPOREAL CIRCULATION SYSTEM MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 192. EXTRACORPOREAL CIRCULATION SYSTEM MARKET, FPNV POSITIONING MATRIX, 2023